Key Takeaways Stanford researchers discovered a naturally occurring peptide called BRP that may support weight loss through appetite regulation In animal studies, BRP reduced food intake by nearly 50% within one hour and promoted fat loss without major side effects Unlike Ozempic and other GLP-1 drugs, BRP appears to work directly through the brains appetite centers rather than slowing digestion Researchers observed no significant nausea, digestive discomfort, or behavioral changes in animals treated with BRP With obesity rates continuing to rise globally, scientists are searching for safer and more tolerable medical weight loss options Behind the Discovery: What Is BRP
So far, no compounding pharmacy has been fined or lost their license in Louisiana and Mississippi, according to state regulators
PlexusDx helps clarify your personalized response through genetic insights and ongoing medical support
Semaglutide has an equivalent non-invasive option that does not carry similar risks, with close outcomes without the invasive potential complications
AEs leading to trial product discontinuation occurred in 51/603 (8.5%) participants in the CagriSema 2.4 mg/2.4 mg group, 40/605 (6.6%) participants in the semaglutide 2.4 mg group, 7/152 (4.6%) participants in the cagrilintide 2.4 mg group, 42/594 (7.1%) participants in the CagriSema 1 mg/1 mg group, 26/608 (4.3%) participants in the semaglutide 1 mg group, and 2/149 (1.3%) participants in the placebo group
